{"componentChunkName":"component---src-components-blog-blog-post-jsx","path":"/blog/approaching-life-sciences-fundraising/","result":{"pageContext":{"contentfulData":{"title":"Guide: How to approach Life Sciences fundraising","date":"2020-01-27","heroImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"9J2zakPYz4XTKbTjw8aZm","type":"Asset","createdAt":"2020-02-05T00:07:53.629Z","updatedAt":"2020-02-05T00:07:53.629Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/9J2zakPYz4XTKbTjw8aZm/41f1d44f4a74722b07904448901b86ac/retina__1_.png","details":{"size":95930,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}},"heroImgAlt":"approach Life Sciences fundraising","body":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Foreword","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"Dear biotech colleagues,","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Without access to affordable capital and strategic resources, it’s difficult for small biotechnology companies to navigate the complex world of fundraising and turn their novel concepts into approved medical products. Securing investment at all stages of the business life cycle is a priority for the vast majority of BIO’s member companies and it’s also a key component of our policy efforts in Washington D.C. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"That’s why BIO is working overtime in Washington to preserve our world-leading investment ecosystem and to incentivize invest and innovation. BIO’s strategic advocacy initiatives are focused on preserving strong intellectual property rights and efficient tech transfer, promoting a robust capital formation environment, improving patient access to transformative therapies in development, and preserving market-based pricing for drugs.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"BIO's global portfolio of partnering and investor events also provide a forum to shape deals and drive collaboration. To make this process easier, I’m thrilled to introduce ","nodeType":"text"},{"data":{},"marks":[{"type":"bold"}],"value":"“How to Approach Life Sciences Fundraising.” ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"This report is brought to you by our BIO Business Solutions® Partner, Brex. Designed with your mission in mind, the Brex corporate card for life sciences extends cash runway and streamlines your financial operations so you can spend more time on the work that really matters.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Brex created this report to help our member base navigate the fundraising landscape and outline opportunities for biotechs at various stages of development: government grants, non-government grants, incubators and accelerators, private investment, and large pharma partnerships. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"I hope this report can serve as a helpful roadmap as you pursue the R&D funding that will allow your scientists to create breakthroughs that can change and save lives.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Sincerely, ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Jim Greenwood","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"President & CEO Biotechnology Innovation Organization","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Introduction","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"One of the biggest challenges for life sciences companies is finding sources of funding to keep their research and development moving forward. In this guide, we’ll explore the different sources of funding available to biotech startups and their relative merits, and how you should best utilize that funding at each stage of your research.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"In this industry, there’s no single accepted pathway to fundraise for your startup. Depending on the stage of your research, you may find the pursuit of certain sources of funding to be more cost-efficient than others. For example, if you’re working with just an idea, you’ll want to look for different resources than if you’ve already finished your discovery phase and have some hard data to show to investors. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"It also matters how you spend your funding and at what stage in the process. If you’re just getting started, your funding will probably go toward finding lab space, supplies, and instruments to help you get through discovery. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"If you’re going into a crowded market where multiple competitors are creating innovations to address the same therapeutic solution, you’ll want to find resources that will get your product to market in the fastest, most efficient way—perhaps by recruiting experienced researchers and administrators to grow your team. You’ll want to consult with law firms for advice on filing for patent protection and work with a business development consultancy to facilitate partnerships with big pharmaceutical companies. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"No matter the challenge, we want to help your company examine its fundraising options.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"1. Government grants","nodeType":"text"}],"nodeType":"heading-2"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2uBFOSfpv11T8fRANL96Sd","type":"Asset","createdAt":"2020-01-27T20:31:29.903Z","updatedAt":"2020-01-27T20:31:29.903Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"government grants","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2uBFOSfpv11T8fRANL96Sd/e8e1463197d7b8d94900de2f26173639/retina__2___1_.png","details":{"size":131918,"image":{"width":700,"height":400}},"fileName":"retina (2) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Government grants are a significant source of funding for researchers looking to get their idea off the ground and as such they can be highly competitive. Depending on the agency or organization offering the grants, they have widely varying eligibility, submission, and audit requirements, as well as awards. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The first step is identifying the grants that suit the stage of research that you’re currently in. If you have a well-developed hypothesis with concrete goals, you may be able to find a grant to help you reach a certain milestone. If you’re confident about your direction but still want to test out a few different therapeutic candidates, there are grants to help you run a pilot or feasibility study. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2JGrvwdtV8K8isYDHBwXRv","type":"Asset","createdAt":"2020-01-27T20:33:09.032Z","updatedAt":"2020-01-27T20:33:09.032Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2JGrvwdtV8K8isYDHBwXRv/7f55311ff6e99e27dafd9e6f4eded8a5/retina__1_.png","details":{"size":95567,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Types of government grants","nodeType":"text"}],"nodeType":"heading-4"},{"data":{},"content":[{"data":{},"marks":[],"value":"The biggest sources of biotech government grants are the ","nodeType":"text"},{"data":{"uri":"https://sbir.nih.gov/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"National Institutes of Health","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" (NIH), the ","nodeType":"text"},{"data":{"uri":"https://www.grants.gov/learn-grants/grant-making-agencies/department-of-defense.html"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Department of Defense","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" (DoD), the ","nodeType":"text"},{"data":{"uri":"https://www.nsf.gov/funding/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"National Science Foundation","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" (NSF), the ","nodeType":"text"},{"data":{"uri":"https://www.cdc.gov/grants/index.html"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Centers for Disease Control","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" (CDC), and the ","nodeType":"text"},{"data":{"uri":"https://medicalcountermeasures.gov/barda/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Biomedical Advanced Research and Development ","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://sbir.nih.gov/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://medicalcountermeasures.gov/barda/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Authority","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" (BARDA). Check out ","nodeType":"text"},{"data":{"uri":"http://grants.gov"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"grants.gov","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" for a massive list of grant opportunities and other grant-making government agencies. You can apply for grants manually during regular submission windows, or keep your eye out for Funding Opportunity Announcements (FOAs), where agencies solicit researchers to compete for a specific targeted research output.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Of these, the NIH is perhaps the largest source of funding for up-and-coming biotechs—it pours almost $1 billion each year into small life sciences companies with the mission of creating technologies that seek fundamental knowledge about nature, the behavior of living systems, and the application of that knowledge to improve human health. It offers two major federal grant programs, the Small Business Innovation Research (","nodeType":"text"},{"data":{"uri":"https://www.sbir.gov/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"SBIR","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":") grant or the Small Business Technology Transfer (","nodeType":"text"},{"data":{"uri":"https://www.sbir.gov/about/about-sttr"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"STTR","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":") grant.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The SBIR program encourages US-based small businesses to engage in research and/or R&D that has the potential for commercialization. Its sister program, STTR, is designed to facilitate cooperative R&D between small businesses and non-profit research institutions. The NIH is made up of 27 different institutes and centers (ICs), most of which have SBIR and STTR programs. Because each IC has a different focus area (the National Institute of Mental Health, for instance, or the National Heart, Lung, and Blood Institute), you’ll want to apply for the SBIR or STTR with the institute that has the best fit for your research. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"SBIR/STTR programs have roughly three phases: Discovery, Development, and Commercialization. Each phase requires that the potential awardee demonstrates technical merit, feasibility, and the commercial potential for the proposed R&D efforts. The awards scale with the phases: in Discovery, awards don’t normally exceed $150,000 over six months, while in Development, the standard award is $1 million over two years. Though you typically have to apply for, win, and then demonstrate success in each phase in order to be eligible for the next phase, there are Fast-Track Applications that allow you to jump ahead in the process and seek larger award amounts.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Grant-writing tips","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"Grant applications are often laborious and can be highly idiosyncratic to the agency at hand. The best applications tend to be strong in these key areas:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Scientific merit.","nodeType":"text"},{"data":{},"marks":[],"value":" Awardee has experience with essential methodologies, clearly defined tests for feasibility, a solid experimental approach that considers potential pitfalls or alternatives, and a focused, coherent research plan. ","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Eligibility. ","nodeType":"text"},{"data":{},"marks":[],"value":"Awardee’s research area fits in with the IC content focus, awardee’s business or research consortium fits in with the small business bracket, and amount of work proposed is realistic and achievable with the award scope. ","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Commercialization potential. ","nodeType":"text"},{"data":{},"marks":[],"value":"This is more critical for grants that apply to later phases of research. Awardee understands the basic market for the research, has a clear commercialization scheme, and their research represents a clear innovation within the IC’s field.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"Key takeaways","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Great funding source for startups. ","nodeType":"text"},{"data":{},"marks":[],"value":"Generally, grants are appropriate for startups where, due to basic resource constraints or lack of hard data, it’s too early to seek private investment. They can help small life sciences companies transition from having a promising idea to something that is commercially viable and of greater interest to investors.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Diversification is important. ","nodeType":"text"},{"data":{},"marks":[],"value":"The final spending bill in 2020 raised funding for the sciences; the NIH will receive a 7% boost to funding in the upcoming fiscal year, bringing its total budget to $41.7 billion. Even so, it’s still prudent to diversify your sources of funding. Grants like the SBIR/STTR are fiercely competitive. 2020 may be a good year for government funding, but the proportion of U.S. R&D supported by ","nodeType":"text"},{"data":{"uri":"https://www.nsf.gov/statistics/2018/nsb20181/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"federal funds has been on the decline","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", falling from nearly 70% in 1973 to 60% in 2018. It’s best to look for multiple sources of funding in case one grant falls through or you aren’t approved for the next grant program phase.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"\n","nodeType":"text"},{"data":{},"marks":[{"type":"bold"}],"value":"Grants lend legitimacy. ","nodeType":"text"},{"data":{},"marks":[],"value":"Grants drive the science in those early days when it’s difficult to get institutional investors interested in a pre-clinical asset. But they also serve to validate your technology and put the brand of the IC behind your research. Getting a big-name government grant associated with your research will give you a leg up in raising funds later on in development, because investors trust that the government wouldn’t invest in your science unless it was solid.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Pros and cons of government grants","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Pros:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Helpful in getting your idea off the ground.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Non-dilutive. You don’t have to give up equity in your research.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Prestigious grants help attract attention for more fundraising.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Cons:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Audits and accounting for multiple grant sources can be onerous. ","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Gov’t grants may have specific award conditions that require you to use the funding on certain things.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Gov’t grants are highly competitive, so you may spend a lot of time applying with a low success rate.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"2. Non-government grants","nodeType":"text"}],"nodeType":"heading-2"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"7eW4vbEFYaXnsyc8WmZvFD","type":"Asset","createdAt":"2020-01-27T20:35:45.894Z","updatedAt":"2020-01-27T20:35:45.894Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (2) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/7eW4vbEFYaXnsyc8WmZvFD/406d9bddf590d2cca360c0ec918b4672/retina__2___1_.png","details":{"size":114291,"image":{"width":700,"height":400}},"fileName":"retina (2) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Government grants are by no means the only source of non-dilutive funding out there. They may have a reputation for being the most competitive and prestigious, but funding from a well-known advocacy group like the American Cancer Society or a corporate foundation certainly comes with credibility and brand-recognition. They also may be comparatively looser in their auditing requirements or award conditions.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"4WwzbeVVFnXyC4M0e8NlLC","type":"Asset","createdAt":"2020-01-27T20:37:01.314Z","updatedAt":"2020-01-27T20:37:14.512Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":2,"locale":"en-US"},"fields":{"title":"retina","file":{"url":"//images.ctfassets.net/qlyedcbd6576/4WwzbeVVFnXyC4M0e8NlLC/6abe7033b1ba9ba95e3d66c3917f7306/retina__1_.png","details":{"size":128693,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Patient advocacy groups","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"Also known as voluntary health agencies or nonprofit disease foundations, patient advocacy groups are composed of mission-driven individuals seeking to combat a particular disease, disability, or group of disorders. They’re organized by a mix of laypeople and professionals, and they often work closely with doctors and large pharma. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Many of them fund research on their particular area, like the American Diabetes Association, the Parkinson’s Disease Foundation, the American Lung Association, or the Alzheimer’s Association. The National Health Council has a large ","nodeType":"text"},{"data":{"uri":"http://www.nationalhealthcouncil.org/about-nhc/membership-directory"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"membership directory","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" of 125 national health-related organizations. If your area of research is in alignment with the advocacy group’s mandate, they may offer a grant program. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Family offices and foundations","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"These foundations are set up by wealthy families to support specific causes or sets of causes. They often invest in areas they believe in or to which they have a personal connection. Social impact, often in the arena of human health, is a major focus of family foundations—the Bill and Melinda Gates Foundation is a great example. Because family offices are often a vehicle by which wealth can be passed down to the family’s next generation, they may also offer investment in projects that have solid potential for commercialization.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"There are indications that family offices are ","nodeType":"text"},{"data":{"uri":"https://www.forbes.com/sites/francoisbotha/2018/12/17/the-rise-of-the-family-office-where-do-they-go-beyond-2019/#598a46435795"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"on the rise","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", with a 10-fold growth in offices over the last decade. Some research puts the assets that family offices currently hold in excess of $4 trillion, so this may be a funding source to keep an eye on.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3ObgCdsFecvFOBLuU92Q5o","type":"Asset","createdAt":"2020-01-27T20:39:05.117Z","updatedAt":"2020-01-27T20:39:05.117Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3ObgCdsFecvFOBLuU92Q5o/dad94946ccaf924c8e5b5b1a9c5cea47/retina__1_.png","details":{"size":152319,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Corporate foundations","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"A 2018 ","nodeType":"text"},{"data":{"uri":"https://www2.deloitte.com/content/dam/Deloitte/us/Documents/about-deloitte/us-about-deloitte-foundations-in-life-sciences-and-health-care.pdf"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Deloitte report","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" shows that large life sciences corporations are increasingly pouring resources into corporate philanthropy organizations in order to improve consumer brand approval, communicate their key beliefs, inspire their stakeholders, and position themselves as constructive forces in their industry ecosystem. Major forces like pharmaceutical giants are also well-suited to understand the complex multi-year issues that life sciences startups face in creating new technologies and therapeutic candidates, especially in their specific areas of focus.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The Novartis Foundation, the philanthropy wing of the global healthcare company, is an instructive example. They’ve chosen to leverage the corporate organization’s expertise in cardiovascular health and noncommunicable diseases to fuel the foundation’s global health programs. As part of their effort to improve chronic health conditions like hypertension, they’ve funded a wide variety of organizations that, brought together, stand to make a more effective intervention.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"\nIf you’re a startup with some decent initial data on your therapeutic candidate and an understanding of the industry landscape surrounding your research area, it may be fruitful to reach out to corporate foundations that are operating in similar arenas. The model of corporate philanthropy is shifting away from one-off charitable gifts toward one of targeted, strategic partnerships. If you can position your research as a valuable potential tool to help them achieve their goal, they may offer you financial backing. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2bLdVNze57r5OyccHeCxNj","type":"Asset","createdAt":"2020-01-27T20:41:00.805Z","updatedAt":"2020-01-27T20:41:00.805Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (3) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2bLdVNze57r5OyccHeCxNj/676c488241e5df495b39335bc9baccea/retina__3___1_.png","details":{"size":92059,"image":{"width":700,"height":400}},"fileName":"retina (3) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Key takeaways","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Know your industry. ","nodeType":"text"},{"data":{},"marks":[],"value":"Get familiar with the major corporate players, philanthropy sources, and research consortiums in your area of focus. Approach the foundations and companies that have skin in your game. Keep an eye out for grant opportunities.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Tell the right story.","nodeType":"text"},{"data":{},"marks":[],"value":" When you approach funders, know how to frame your research as a potential tool that they can use to make better interventions. If you can show that your work represents an improvement on their current framework, they see you as another potential player to help them achieve their multidisciplinary goal.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Focus on getting through discovery. ","nodeType":"text"},{"data":{},"marks":[],"value":"Especially when pitching to larger corporate funders or their foundations, be aware that they will want to validate your research and feel confident that it can address their needs. You’ll want to focus on getting some solid initial data to show them.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Pros and Cons of non-government grants","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Pros:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Non-dilutive. You don’t have to give up equity in your research.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"As a time investment, somewhat less risky than applying for gov’t grants.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Fewer award conditions on grants, though they still exist.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Prestigious grants or partnerships with corporate clients help future rounds of fundraising.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Cons:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Requires you to have solid data to show that your research has promise. ","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Requires knowing how to pitch to a major corporation.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"3. Incubators and accelerators","nodeType":"text"}],"nodeType":"heading-2"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"7jNC4FoOWjzCmwlnZ1Qh7B","type":"Asset","createdAt":"2020-01-27T20:43:03.510Z","updatedAt":"2020-01-27T20:43:03.510Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/7jNC4FoOWjzCmwlnZ1Qh7B/fb9f399c19fb22af4c6f41e60da5ecb5/retina__1_.png","details":{"size":167563,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Incubators and accelerators are a major source of funding for life sciences startups. A new ","nodeType":"text"},{"data":{"uri":"https://www.svb.com/blogs/ben-johnson/how-life-science-accelerators-drive-innovation"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Silicon Valley Bank report","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" finds that one in four life sciences startups that raised at least $4 million in 2017-2018 worked with an accelerator or incubator at some point in their lifecycle. The report found that they gave startups a significant boost by providing early stage support and sometimes a followup funding round.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6XlnLdCKZUu5A7blLQdUDz","type":"Asset","createdAt":"2020-01-27T20:46:37.200Z","updatedAt":"2020-01-27T20:46:37.200Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/6XlnLdCKZUu5A7blLQdUDz/d38cd909c4aa7dea17badae5cc15ec61/retina__1_.png","details":{"size":124414,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"It’s common for new life sciences startups to seek out incubators because it helps them save money, find mentorship, and develop business acumen. They can offer fledgling research projects the breathing room they need to validate their initial theories or therapeutic candidates while they apply for grants or attract other investment. Accelerators tend to work with more advanced-stage startups that already have a minimally viable product. Some—","nodeType":"text"},{"data":{"uri":"https://indiebio.co/about/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"IndieBio","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" and ","nodeType":"text"},{"data":{"uri":"https://www.ycombinator.com/biotech/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Y Combinator","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" are good examples—may even offer seed funding.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Savings","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"Incubators usually provide lab space, lab supplies, and access to specialized equipment—plate readers, centrifuges, HPLC systems. Some incubators have lab managers and technicians on hand to help accelerate your research. Others, like ","nodeType":"text"},{"data":{"uri":"https://www.mothershiplab.com/startup-resources"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Mothership Lab","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", offer incorporation and legal advice, product and brand design services, and industrial design and fabrication. It all goes toward freeing up time for more research, more fine-tuning of technology to prepare for clinical trials or commercialization. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2uBFOSfpv11T8fRANL96Sd","type":"Asset","createdAt":"2020-01-27T20:31:29.903Z","updatedAt":"2020-01-27T20:31:29.903Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"government grants","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2uBFOSfpv11T8fRANL96Sd/e8e1463197d7b8d94900de2f26173639/retina__2___1_.png","details":{"size":131918,"image":{"width":700,"height":400}},"fileName":"retina (2) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Administrative and research expertise","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"At the start, many life sciences startups face the challenge of dealing with the bureaucracy underlying biotech research. Incubators can help startups with implementing safety regulations and adopting waste disposal best practices, for example. They may also offer mentorship programs with experts in the field of life sciences research, who can give feedback on your methodology, help you see blind spots you’ve missed, or advise you on a commercialization scheme. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Some incubators are associated with or run by major pharmaceutical companies, which offer access to deep-seated industry knowledge. Pfizer’s ","nodeType":"text"},{"data":{"uri":"https://www.pfizercti.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Centers for Therapeutic Innovation","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" assigns a renowned researcher to each investigator and project, who helps the startup navigate and make efficient use of the company’s collaborative infrastructure. CTI, like some other pharma-backed incubators, offers this aid in exchange for joint ownership of the intellectual property. ","nodeType":"text"},{"data":{"uri":"https://jlabs.jnjinnovation.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"JLabs","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", the incubator under Johnson & Johnson Innovation, provides similar support while allowing the entrepreneur to hold onto their IP.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Community and networking","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"Incubators can be a great source of community for early-stage investigators. Boston based ","nodeType":"text"},{"data":{"uri":"https://labcentral.org/uploads/assets/impact_report_final_web_5.14.pdf"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"LabCentral","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" places a lot of emphasis on the importance of connecting current cohort members with alumni and other life sciences companies in associated fields, in the belief that shared experience can speed up the pace of innovation. Many incubators host speaker series where you can learn from and interact with world-class scientists in your area of research. They can also attract and connect you to investors: the incubator network ","nodeType":"text"},{"data":{"uri":"https://qb3.org/about"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"QB3","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", for instance, has an annual summit that introduces their startup cohorts to investors and industry partners. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5rQt8LYooMDIEzYmh3wPhC","type":"Asset","createdAt":"2020-01-27T20:48:59.691Z","updatedAt":"2020-01-27T20:48:59.691Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5rQt8LYooMDIEzYmh3wPhC/47a1b5eabc6fe2d8e85589eda0af3884/retina__1_.png","details":{"size":129208,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Key takeaways","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Define the help you need to get started. ","nodeType":"text"},{"data":{},"marks":[],"value":"Incubators and accelerators offer a variety of support services for life sciences startups at various stages. Consider what your end goal is and which business areas you need most help in developing. If you’re happy with your discovery data but don’t feel confident about finding investment, look for an accelerator that can train you on business development and pitching to investors. If you’ve got an exciting idea but limited resources, look for an incubator that can help you allocate your existing funding efficiently.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Be aware of what you’re trading in return. ","nodeType":"text"},{"data":{},"marks":[],"value":"Some incubators just require a monthly or yearly membership fee in exchange for lab space, supplies, and expertise. But others—especially accelerators and corporate-affiliated incubators—may require a share in your IP or an exclusivity agreement in developing any product that comes from launch. You may want to consult with a business development expert to weigh your options.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Pros and cons of incubators and accelerators","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Pros","nodeType":"text"},{"data":{},"marks":[],"value":":","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"You don’t have to worry about finding and managing lab space or ordering lab supplies.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Business development programming and networking opportunities.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Reputation boost from being associated with a prestigious incubator can help with later fundraising.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Depending on the accelerator, seed funding may be available.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Cons:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Application process is rigorous and competitive.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"For accelerators, you may need to submit a substantial business plan, including market analysis, a refined pitch and hard research data.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Some incubators require a time commitment and adherence to a schedule.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"4. Private investment","nodeType":"text"}],"nodeType":"heading-2"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"33kmk4fMHJOWWDipsSUW6s","type":"Asset","createdAt":"2020-01-27T20:50:30.738Z","updatedAt":"2020-01-27T20:50:30.738Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (2) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/33kmk4fMHJOWWDipsSUW6s/e1cb55db6601ec8e12fdf99d394aeca5/retina__2___1_.png","details":{"size":94625,"image":{"width":700,"height":400}},"fileName":"retina (2) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Many startups go after private investment because they don’t have time to wait for SBIR funding or go through an incubator program. This is particularly true if you’re competing with several other technologies chasing the same clinical market and your competitors have a lead on you. As you progress and become more confident in the efficacy of your end product—and as your expenses scale with the complexity of your research—it becomes important to seek private investment in addition to grant funding. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5Z7oQroFpAZZujRRV3PcX7","type":"Asset","createdAt":"2020-01-27T20:51:21.640Z","updatedAt":"2020-01-27T20:51:21.640Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (3) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5Z7oQroFpAZZujRRV3PcX7/db5ca21f789f6d05d8739bee971dfc7b/retina__3___1_.png","details":{"size":120499,"image":{"width":700,"height":400}},"fileName":"retina (3) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Angel investors","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"If you’re in the early stages of your research and you’re already working hard on creating a network of industry specialists, you might be able to seek private investment from a wealthy domain expert. Especially if you’re trying to fundraise before you have intriguing data and you need the resources to support R&D, approaching someone who understands your space and will trust your instincts is key. If anyone’s going to take a risk on a proposal that is, at this stage, little more than an idea, it’s going to be someone who understands the technology or methodology upon which your hypothesis is based.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"It’s hard to depend on this source of capital. Having the time to prioritize networking is a luxury that most early startups don’t have, particularly in life sciences. You also have to have the communication skills to convince potential angels of your vision. For most early-stage startups, the best course is usually to invest in networking for its general benefits rather than solely to forge relationships with angel investors. For instance, giving and attending presentations at industry conferences is usually worthwhile for its own merits—it gets your name out there, helps you learn more about your industry, meet potential future collaborators and understand your competition. If you happen to meet a potential investor, it’s icing on the cake.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"If you’re a later-stage startup in search of angels, the Angel Capital Association has a comprehensive ","nodeType":"text"},{"data":{"uri":"https://www.angelcapitalassociation.org/directory/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"directory","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" of angel networks that may help you get started in your search. ","nodeType":"text"},{"data":{"uri":"https://lifescienceangels.com/about/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Life Sciences Angels","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" is a network worth noting, as well. It was founded by life sciences executives and experienced angel investors and functions as a sort of angel investment/venture capital hybrid focused on funding early-stage biotech and medical device companies. You might also check out ","nodeType":"text"},{"data":{"uri":"https://www.techcoastangels.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Tech Coast Angels","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"https://www.keiretsuforum.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Keiretsu Forum","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", and ","nodeType":"text"},{"data":{"uri":"https://www.sandhillangels.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Sandhill Angels","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":".","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3KSmH4xehfvUGlJZC5B3wX","type":"Asset","createdAt":"2020-01-27T20:52:52.887Z","updatedAt":"2020-01-27T20:52:52.887Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3KSmH4xehfvUGlJZC5B3wX/dcb9ad9f63f075089a396ea646ca1859/retina__1_.png","details":{"size":110575,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Venture capital","nodeType":"text"}],"nodeType":"heading-4"},{"data":{},"content":[{"data":{},"marks":[],"value":"Corporate venture capital is a massive source of funding for biotech startups. Large pharma companies like Pfizer, GlaxoSmithKline, AstraZeneca, Takeda, Novo Nordisk and others have funding arms that, alongside traditional venture capital firms, co-invest in young biotechs. There’s some ","nodeType":"text"},{"data":{"uri":"https://techcrunch.com/2019/03/23/corporate-biotech-venture-funding-rises-again/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"speculation","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" that this represents an industry trend toward moving R&D efforts out of in-house pharma labs and into venture-backed startup labs. In 2018, biotech startups raised almost $29b in seed funding, up from $19 billion in 2017.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"551FscFgzOrVEg672oYeUt","type":"Asset","createdAt":"2020-01-27T20:53:31.177Z","updatedAt":"2020-01-27T20:53:31.177Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (2) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/551FscFgzOrVEg672oYeUt/ff5fc951ca75704ec9aa3d16fb4d21fd/retina__2___1_.png","details":{"size":90724,"image":{"width":700,"height":400}},"fileName":"retina (2) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"It’s not just pharma-backed corporate VCs that are active in biotech investing. Tech companies like Apple, Amazon, Microsoft, and Google have become increasingly invested in the healthcare industry. While for the most part they’ve focused on the consumer side, Google Ventures has funded a number of biotech companies. ","nodeType":"text"},{"data":{"uri":"https://www.bloomberg.com/news/articles/2019-02-11/google-s-venture-firm-taps-biotech-veteran-in-life-sciences-push"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"GV recently hired","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" biotech industry veteran David Schenkein to co-lead its investments in life sciences, signalling increased interest in the space.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Traditional venture capital is a big player in the life sciences investing world, as well. Firms like ","nodeType":"text"},{"data":{"uri":"https://www.domainvc.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Domain","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"https://www.sofinnova.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Sofinnova","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"https://www.versantventures.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Versant","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"http://www.orbimed.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"OrbiMed","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" and ","nodeType":"text"},{"data":{"uri":"https://5amventures.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"5AM Ventures","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" have historically focused mostly on life sciences, while others spread their investments across a number of industries, such as ","nodeType":"text"},{"data":{"uri":"https://www.nea.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"NEA","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"https://www.canaan.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Canaan Partners","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", and ","nodeType":"text"},{"data":{"uri":"https://www.kleinerperkins.com/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Kleiner Perkins","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"It’s much harder to secure the confidence of VC firms than it is to win a grant, but similar challenges apply. Unless you have a track record of substantial success in other companies, you’ll need to have impressive data to show investors. Because the nature of life sciences means that R&D takes a lot of time, you’ll want to bring as much proof as possible that your research represents a low-risk investment. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"You should consult with a corporate development team and your attorney to help you understand your market and shape your pitch in the context of your competitors. Many of the largest law firms have a life sciences-specific practice and can be helpful in identifying the best-fit VC firm for you. Mentors associated with incubators and accelerators are often connected to venture capitalists and can make introductions for you. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6lpB8TFv4cLrZH3vcOuwS3","type":"Asset","createdAt":"2020-01-27T20:54:54.866Z","updatedAt":"2020-01-27T20:54:54.866Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/6lpB8TFv4cLrZH3vcOuwS3/69e170ba2a9d1ab2c452a6811369e797/retina__1_.png","details":{"size":98256,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Key takeaways","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Have a good story.","nodeType":"text"},{"data":{},"marks":[],"value":" It’s not enough to have good data, though that is essential. You need to shape what data you have into a story that convinces investors that your research stands to solve a critical problem for a certain clinical market or, better yet, that it represents a major innovation for the industry. This story should be backed up by solid market research, competitor analysis, and a business plan that demonstrates a clear path to profitability.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Make sure you understand what you’re signing up for. ","nodeType":"text"},{"data":{},"marks":[],"value":"Be sure to understand how much your VC expects to be involved in or have input on your process. Having funding is obviously important to move your research forward, but if you stand to lose a substantial amount of autonomy, it may be worth thinking about looking elsewhere.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Timing is important.","nodeType":"text"},{"data":{},"marks":[],"value":" What are you going to use this funding for? Venture capitalists will want to know what their money is going toward. But more to the point, it’s important not to give away too much equity too early. Map out each important milestone between the present state and your exit. Is this round of funding essential to getting past a major milestone, such as clinical trials? You’ll want to work with legal counsel and business development consultants to make sure that you’re not giving away too much of your company, particularly if you’ll need another large round of funding in the future.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Pros and cons of private investment","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Pros:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Source of major funding and stability in later phases of R&D, where risks and financial needs compound.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Reputation boost from being associated with a prestigious angel investor or VC firm can help with later fundraising.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Cons:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"The bar for a successful pitch is high. VCs and investors need to know they’re investing in promising research with strong potential for return.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"A good pitch requires substantial investment on your part in networking and business development know-how.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"This funding is dilutive. Engage legal counsel and work with BD teams to ensure this is the right move for you.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"5. Partnerships with Large Pharma","nodeType":"text"}],"nodeType":"heading-2"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6cw44cw0Z3HvrH7Kc9AXCm","type":"Asset","createdAt":"2020-01-27T20:56:25.322Z","updatedAt":"2020-01-27T20:56:25.322Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (2) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/6cw44cw0Z3HvrH7Kc9AXCm/581ea7e2aab6b96af48a5158178a1491/retina__2___1_.png","details":{"size":192318,"image":{"width":700,"height":400}},"fileName":"retina (2) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Partnerships between large pharmaceutical companies and small biotechs are foundational to the life sciences industry. Large pharma spends an enormous amount of capital on R&D for drug development and medical devices, depending on infusions of new ideas and innovations from biotech startups to keep their business model flexible and competitive. From 2007 to 2016, the industry ","nodeType":"text"},{"data":{"uri":"https://www.drugdiscoverytrends.com/the-marriage-of-big-pharma-and-biotech/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"invested","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" around $1.4 trillion in R&D, or about 14% of its revenues for that period. It’s also no surprise that startup biotechs often look for partnerships with established pharmaceutical companies with substantial capital in reserve. By some ","nodeType":"text"},{"data":{"uri":"https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"estimates","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", with prolonged and uncertain R&D process, clinical trials, and the costs baked into getting regulatory approval, it can take over $2 billion to take a new drug to market.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"7FdL6PXn7qM6ED6RQui0Zp","type":"Asset","createdAt":"2020-01-27T20:58:25.141Z","updatedAt":"2020-01-27T20:58:25.141Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (3) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/7FdL6PXn7qM6ED6RQui0Zp/62c930a5ee7dfa8bdb8adc107b36b362/retina__3___1_.png","details":{"size":129436,"image":{"width":700,"height":400}},"fileName":"retina (3) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"It’s particularly common for biotechs and pharmaceutical companies to collaborate on clinical trials for drugs. Biotechs’ more agile, targeted research model and pharma’s ability to absorb some of the risk of development and provide rich infrastructure make these kinds of partnerships effective. And if you’re a mission-driven researcher who cares first and foremost about improving human health, partnering with pharma can take all business and fundraising work off of your plate altogether.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"If you pursue a partnership with a pharmaceutical company, you’ll often be able to share their resources, like lab space, supplies, and desk space. In addition to helping you shepherd your research through clinical trials, they typically have plenty of experience in dealing with the FDA. When it comes time to go to market, large pharma often has established relationships with contract manufacturing organizations to create and package your product. You’ll also be able to leverage their in-house distribution and marketing functions. The downside, of course, is that by partnering with pharma, you’re often giving up direct control over your business and/or over the IP of your product. Some biotechs may choose to license their IP out to large pharma. The pharma company will do licensing deals in exchange for an upfront lump sum and royalties—which biotechs use to fund other projects or start new research.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"There are several pathways to starting a relationship with large pharma. Mid-sized biotechs will often hire a VP of Business Development to help them solicit partnerships, sometimes directly out of large pharma companies themselves. There are also a variety of business development consulting firms that focus on helping life science clients identify the best potential partners and help them negotiate contracts. The major life science conferences—the ","nodeType":"text"},{"data":{"uri":"https://www.bio.org/events/bio-international-convention"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"BIO International Convention","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"https://informaconnect.com/biopharm-america/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"BioPharm America","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", and ","nodeType":"text"},{"data":{"uri":"https://informaconnect.com/bioeurope-spring/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"BioEurope","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", for example—provide systems and events for facilitating partnerships between biotechs and large pharma.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Key takeaways","nodeType":"text"}],"nodeType":"heading-4"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Due diligence is often a sticking point. ","nodeType":"text"},{"data":{},"marks":[],"value":"If a pharmaceutical company is interested in partnering with or acquiring your business, be ready to provide granular data on your research thus far. Pull all your references, market research, and research data together into one data room and keep it well-organized. Some pharma partners will see disorganization as a warning sign.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Work with legal counsel on the structure of your contract. ","nodeType":"text"},{"data":{},"marks":[],"value":"Make sure you understand what you’re giving in exchange for pharma help in bringing your product to market. If you’re a first-time startup biotech, pharmaceutical companies will likely have much more experience than you in structuring a partnership that works to their advantage. Think carefully about what you want to accomplish (getting through clinical trials, business development, regulatory advice) and make sure that whatever royalties or equity in your company you give up is worth the expertise you’ll receive from pharma. You’ll also want to consult with business development consultants and financial advisors.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Culture fit is important. ","nodeType":"text"},{"data":{},"marks":[],"value":"Up to the point of getting a partnership with pharma, you’re probably laser-focused on the search for hard empirical data to back up your idea and the most effective story for your pitch. But it’s important to remember that you’ll be entering a large community with substantial inertia and an established way of doing business. Before you sign any papers, make sure you and the pharma partner are aligned on company culture. Ideally, the partner should help you navigate industry complexity and respect your need for flexibility, speed, and autonomy.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Pros and cons of partnerships with large pharma","nodeType":"text"}],"nodeType":"heading-4"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Pros:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"You get to focus on the science. No need to worry about administration, business development, basic resourcing.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Go-to-market is largely taken off your plate.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Pharma has deep experience in conducting clinical trials and working with the FDA.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Cons:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Partnerships are dilutive. You’re likely giving up some proportion of the rights to your IP.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"The bar for a successful pitch is high. Large pharma needs to know they’re investing in promising research that will bring a product to market.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Rigorous due diligence process. Make sure your data is meticulously detailed and ready for review by the partner.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"Conclusion","nodeType":"text"}],"nodeType":"heading-2"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"1rqzh1afFUKtLtiCWI9PDp","type":"Asset","createdAt":"2020-01-27T20:58:47.054Z","updatedAt":"2020-01-27T20:58:47.054Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (4) (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/1rqzh1afFUKtLtiCWI9PDp/c1e56b281a259d16ff23379efdf6b511/retina__4___1_.png","details":{"size":164280,"image":{"width":700,"height":400}},"fileName":"retina (4) (1).png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Effective fundraising—at the right moment, for the right reasons—is crucial to bringing your idea to market and making an impact on human health. It’s a good idea to have a couple of irons in the fire at any given moment, whether that’s grant funding from multiple sources or relationships with private investors, to ensure that your runway doesn’t end before your research does. And in the meantime, there are ways to make the funding you’ve got stretch further. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Brex’s corporate credit card for life sciences companies","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" doesn’t require personal guarantees, personal credit scores, or security deposits from founders, giving you ","nodeType":"text"},{"data":{"uri":"https://brex.com/solution/high-spending-limits/"},"content":[{"data":{},"marks":[],"value":"10-20x higher limits","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" than traditional corporate cards. We’ve also built a card program specifically for life sciences, with rewards and perks unique to your industry—you get 7x points back on conference tickets, 4x on travel, 2x on lab supplies, discounts on subscription services, and more. And if grants are your primary funding source, we offer automated receipt-matching and accounting integrations to help organize your bookkeeping and simplify your audits.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"},"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5TXR4rjZfywsaWyW2Oucmm","type":"Entry","createdAt":"2018-12-04T23:35:17.306Z","updatedAt":"2019-04-25T05:00:31.009Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":3,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Fundraising"}},"urlPath":"approaching-life-sciences-fundraising","author":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"40seojk2QHeO5absAg3ugn","type":"Entry","createdAt":"2019-12-19T13:39:27.158Z","updatedAt":"2019-12-19T13:39:27.158Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"author"}},"locale":"en-US"},"fields":{"name":"Brian Henderson","picture":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3oeROKXowwuoXanycdrtPb","type":"Asset","createdAt":"2019-12-19T13:38:36.056Z","updatedAt":"2019-12-19T13:38:36.056Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"IMG 3165","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3oeROKXowwuoXanycdrtPb/80eb13832f9e1b2d6401bfe7e541508f/IMG_3165.jpeg","details":{"size":124119,"image":{"width":1206,"height":1118}},"fileName":"IMG_3165.jpeg","contentType":"image/jpeg"}}},"description":"Brian Henderson is a content writer at Brex. He’s been a product marketing manager and copywriter in San Francisco for 10 years, most recently at Square and Uber.","biography":"Brian Henderson is a content writer at Brex. He’s been a product marketing manager and copywriter in San Francisco for 10 years, most recently at Square and Uber."}},"isTopPost":false,"shouldFeature":false,"metaDescriptionTag":"One of the biggest challenges for life sciences companies is finding sources of funding to keep their R&D moving forward. This guide, will explore the different sources of funding available to biotech startups and how you should best utilize that funding at each stage of your research.","metaTitleTag":"Guide: How to approach Life Sciences fundraising","thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2dW13OSSFTm41guz1MwRPG","type":"Asset","createdAt":"2020-02-05T00:08:06.797Z","updatedAt":"2020-02-05T00:08:06.797Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2dW13OSSFTm41guz1MwRPG/c82dee10d552c1e75d9fbb5881477383/thumbnail__1_.png","details":{"size":33987,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"thumbnailImageRetina":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"9J2zakPYz4XTKbTjw8aZm","type":"Asset","createdAt":"2020-02-05T00:07:53.629Z","updatedAt":"2020-02-05T00:07:53.629Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/9J2zakPYz4XTKbTjw8aZm/41f1d44f4a74722b07904448901b86ac/retina__1_.png","details":{"size":95930,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}},"articleLinks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3ACIjnYKwBegF5MropL5Lf","type":"Entry","createdAt":"2020-01-17T14:57:28.696Z","updatedAt":"2020-01-29T10:33:14.345Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":2,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"title":"How to balance research and business needs in Life Sciences","date":"2020-01-17","heroImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6DCW83P81W841T4R8StTfj","type":"Asset","createdAt":"2020-01-17T14:53:49.103Z","updatedAt":"2020-01-17T14:53:49.103Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/6DCW83P81W841T4R8StTfj/3c7b3373138530bd6d79460f4456d265/retina__1_.png","details":{"size":92059,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}},"heroImgAlt":"life-sciences-business-founder","body":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Running successful life sciences companies requires good science that goes toward filling an unmet medical need. But as any growing company in the life sciences industry knows, it takes more than research acumen to steer your initial concept all the way through to exit. Most of the time, you’re trying to make your funding stretch to the next research milestone, so you can apply for new grants or pitch to potential investors. You’re also looking for ways to cut down on administrative tasks that distract from mission-critical research. ","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"Brex for Life Sciences","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" can help you get back to your research, by taking the burden of financial busywork off your plate and by offering credit card rewards that put precious funding back in your pocket.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Reduce your time-to-science through better expense management","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"As your research progresses, your team will expand and tracking your expenses will become more complex. When Brex customer and biotech company ","nodeType":"text"},{"data":{"uri":"https://brex.com/customers/miroculus/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"Miroculous","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" closed a $17 million funding round in 2018, their Head of Finance, Manuel Sescosse, knew he would have to streamline his expense management before it made the month-end closing process onerous. They were hiring quickly, and Sescosse was already spending too much time chasing down employees for their receipts—including the scientists on his research team, who would prefer to spend their time on R&D.  ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"When you swipe your Brex card, you’ll get a text or ","nodeType":"text"},{"data":{"uri":"https://brex.com/mobile/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"mobile push notification","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" prompting you to reply with a photo of your receipt—and then Brex will automatically match it to the expense. Knowing that his team wouldn’t come to him with piles of of paper receipts freed Sescosse from burdensome ","nodeType":"text"},{"data":{"uri":"https://brex.com/solution/expense-management/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"expense management","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" so he could focus on tightening his operation elsewhere and prepare for the growth ahead.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The same was true for biotech company ","nodeType":"text"},{"data":{"uri":"https://brex.com/customers/othram/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"Othram","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", who recently raised a $4 million Series A funding round. Their lab operates by making large bulk purchases, and their bookkeeper faced a massive task in tracking lab purchases that went toward R&D. Brex’s automatic receipt-capture also comes with the option to include a memo, which gave the admin context for every transaction. It’s been so convenient, they’ve stopped using other expense tracking tools. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Brex allows you to integrate with your accounting tool of choice, such as ","nodeType":"text"},{"data":{"uri":"https://brex.com/integrations/quickbooks/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"QuickBooks","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"https://brex.com/integrations/netsuite/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"NetSuite","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", Xero, and ","nodeType":"text"},{"data":{"uri":"https://brex.com/integrations/expensify/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"Expensify","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". Brex for Life Sciences also gives you a bird’s-eye view on your expenses. Managers can customize the spending limits for each individual user’s corporate card, whether physical or virtual. Every dollar you help your employees save goes toward getting that hard data you need to secure your next funding source. And if you have grant accounting audits to satisfy, having the complete picture of your expenses is crucial to show the grant institution that your funding is truly going toward the award criteria.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Make your funding go farther with Brex card rewards","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"Fundraising in the life science industry is complex. You’re often applying for and managing the audit accounting for a patchwork of funding in the form of grants from various sources. You’re pitching to angel investors, applying to incubators and accelerators, or looking for partnerships with big pharma. Whatever your path, you’re investing a lot of your time and energy into making sure your research has a runway. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Choosing a credit card that gives you points on your research spend is a great way to make sure your current funding lasts long enough to get you to the next milestone. The Brex for Life Sciences credit card allows you to optimize money back to your business. Brex will give you points on subscription services that help you run and grow your company. It offers 10% off your first 90 days of Quartzy spend, a 15% discount on enterprise licenses through Science Exchange, and $5,000 in Amazon Web Services credit over a year, among many others. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"For young biotech companies working on drug development, it's all about getting the data you need to get to clinical trials, and that means burning through lab supplies at a high rate. Many early-stage life science startups will pay for memberships at incubators or accelerators that offer lab space and equipment, or look to partner with pharmaceutical companies who can provide infrastructure and expertise in exchange for equity. Whichever option works best for your disease area, Brex offers 2x points on lab supplies to help you validate your initial therapeutic candidates and attract the attention you need. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"If you’re trying to get your name out there, create a network, and attract private investment, you’ll likely need to do a lot of traveling. You’ll want to meet with patient advocacy groups in your disease area, with family offices and corporate foundations, with angel networks and venture capitalists. You’ll also want to present your research at life sciences industry conferences. The Brex card gives you 4x points on travel booked through Brex and 7x points on conference tickets, which may help you get to that one extra meeting where you land your next source of funding.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Visit the ","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/rewards/?itm_source=website&itm_medium=blog&itm_campaign=balance-research-needs"},"content":[{"data":{},"marks":[],"value":"Brex for Life Sciences","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" page for more details about how the credit card and rewards work.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"},"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"urlPath":"balance-research-business-needs","isTopPost":false,"shouldFeature":false,"metaDescriptionTag":"Extend your runway to the next milestone with Brex for Life Sciences, which offers expense management and credit card rewards tailored for life sciences.","metaTitleTag":"Tips for making your life sciences funding stretch further | Brex","thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"27U85VflTzvthTm0fjIPU2","type":"Asset","createdAt":"2020-01-17T14:53:35.053Z","updatedAt":"2020-01-17T14:53:35.053Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/27U85VflTzvthTm0fjIPU2/c4dfc72146ed29acbbf6aea5c2d95447/thumbnail__1_.png","details":{"size":29780,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"thumbnailImageRetina":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6DCW83P81W841T4R8StTfj","type":"Asset","createdAt":"2020-01-17T14:53:49.103Z","updatedAt":"2020-01-17T14:53:49.103Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/6DCW83P81W841T4R8StTfj/3c7b3373138530bd6d79460f4456d265/retina__1_.png","details":{"size":92059,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}},"articleLinks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5otBpOX03QI96rUGYv0Rvp","type":"Entry","createdAt":"2019-04-25T01:09:19.557Z","updatedAt":"2020-02-05T10:38:10.072Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":10,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5TXR4rjZfywsaWyW2Oucmm","type":"Entry","createdAt":"2018-12-04T23:35:17.306Z","updatedAt":"2019-04-25T05:00:31.009Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":3,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Fundraising"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5c6Kso2aS2XCOoVygoxkg5","type":"Asset","createdAt":"2019-11-25T23:03:49.005Z","updatedAt":"2019-11-25T23:03:49.005Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"Unicorn Round | Brex","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5c6Kso2aS2XCOoVygoxkg5/006665154a0ddc67fbb6f3350cc51164/thumbnail__1_.png","details":{"size":46248,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"raising_a_round","title":"Eight Tools Founders Need to Prepare for a Unicorn Round"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5qyrOXmS5DV792L8a9HKxA","type":"Entry","createdAt":"2019-11-21T18:21:09.565Z","updatedAt":"2019-11-21T18:21:09.565Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5dghPM8m93N5HuVbxgtJMe","type":"Entry","createdAt":"2019-04-09T21:48:44.059Z","updatedAt":"2019-04-09T21:48:44.059Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Scaling"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6oIH5cWIUWyMbab0WsYy3k","type":"Asset","createdAt":"2019-11-21T18:16:57.612Z","updatedAt":"2019-11-21T18:16:57.612Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"Brex - How manual data entry is putting your financial management in jeopardy","file":{"url":"//images.ctfassets.net/qlyedcbd6576/6oIH5cWIUWyMbab0WsYy3k/09ad0f47e87975a112a4ecee40199347/thumbnail__1_.png","details":{"size":31067,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"manual-data-entry-financial-management","title":"How manual data entry is putting your financial management in jeopardy"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3ML403WUfSEe84YG0OiqKY","type":"Entry","createdAt":"2018-12-04T23:26:52.769Z","updatedAt":"2020-02-05T09:42:21.756Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":9,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"4PoCJcrTt6qsqG4ySwYs6E","type":"Entry","createdAt":"2018-12-04T23:24:35.376Z","updatedAt":"2018-12-04T23:24:35.376Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Hiring"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"51Dv0qc5pGmPgYb7dLF5uk","type":"Asset","createdAt":"2019-11-25T22:28:48.731Z","updatedAt":"2019-11-25T22:28:48.731Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"first non technical hire | brex","file":{"url":"//images.ctfassets.net/qlyedcbd6576/51Dv0qc5pGmPgYb7dLF5uk/6772c9f01c8f634d73586a1715c5deed/thumbnail__1_.png","details":{"size":35338,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"first-hire","title":"How to Make the First Non-Technical Hire at Your Startup"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3uUpt9pWHMoVZ0fpGAmlil","type":"Entry","createdAt":"2019-01-29T05:34:24.735Z","updatedAt":"2020-01-29T11:04:02.298Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":11,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2E8gOd5c3dXnb5rwQxalZl","type":"Entry","createdAt":"2019-01-29T05:32:21.430Z","updatedAt":"2019-01-29T05:32:21.430Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Getting Started"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"jRYj9kMeRKiDapAYIf3Fg","type":"Asset","createdAt":"2019-11-15T21:03:27.450Z","updatedAt":"2019-11-15T21:03:27.450Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/jRYj9kMeRKiDapAYIf3Fg/1b8bb6b6412cbf01d4e66fed6ed33398/thumbnail__1_.png","details":{"size":43462,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"accounting","title":"How to Set Up Accounting For Your Startup"}}]}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3Y2mKO0hEzIMG6zPeP984q","type":"Entry","createdAt":"2019-06-18T04:43:54.329Z","updatedAt":"2020-02-05T11:36:16.929Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":10,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"title":"Empowering life sciences with a tailored credit card product","date":"2019-06-18","heroImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3sn9mqK9nyckgLu9SLXryS","type":"Asset","createdAt":"2019-06-18T00:02:21.170Z","updatedAt":"2019-09-04T21:06:18.062Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":2,"locale":"en-US"},"fields":{"title":"man with beaker science","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3sn9mqK9nyckgLu9SLXryS/f08db9c39c3133a7e2ab4f6a2c44297b/c-drying-1629309-unsplash__1_.jpg","details":{"size":99550,"image":{"width":1400,"height":787}},"fileName":"c-drying-1629309-unsplash (1).jpg","contentType":"image/jpeg"}}},"heroImgAlt":"scientist comparing contents of two conical flasks","body":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Science drives innovation. You can thank most of the conveniences you enjoy every day to decades of research in a variety of scientific fields. And at Brex, our goal is to help entrepreneurs achieve their goals — whether that work happens in front of a laptop or in a laboratory.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"That’s why we are very excited to announce that we are officially launching a new vertical: Brex for Life Sciences. We started with the goal of giving founders near-instant access to credit with a dynamic underwriting model. This allowed us to offer a line of credit within minutes of signing up and offer tailored rewards for them. We’ve done the same for ecommerce companies, and are really excited to now take all these learnings to empower researchers and entrepreneurs in life sciences.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"We know life sciences is a different kind of business. Even well-funded companies may still be a long way away from generating revenue. But you still need access to a corporate credit card without a personal guarantee. Thanks to our underwriting technology, which we built from the ground up, we’re able to provide that.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Brex for Life Sciences is a card product that’s tailored specifically to the day-to-day needs of any life sciences company. Life sciences companies can follow the same steps as any other Brex customer to get instant approval for credit. We also offer specialized rewards, including:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"3x rewards points on lab supplies","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"7x on conference tickets","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"4x on Brex Travel","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"1x on everything else","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"The points you earn are also uncapped. You’ll be able to take advantage of our rewards, whatever your needs are as a life sciences company. Whether you’re ordering precision-grade glass in high volume or traveling to conferences around the world, we want to ensure you’re getting the best experience. We’ve also partnered with the California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, to offer the new Brex card with exclusive rewards to CLSA members.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"These tailored rewards come on top of all the other benefits you get with our Brex products. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"24/7 support with wait times under 2 minutes","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Advanced fraud detection and zero liability","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Advanced expense management features and instant receipt capture","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Integrations with top accounting products like QuickBooks and Expensify","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Instant approval for qualified companies that can begin issuing virtual cards immediately","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"We’re excited to already be working with several life sciences companies, including Anthos Therapeutics and Synthego. [These companies focus on cures for cardiovascular disease, genome engineering, and more]. Like our tech and ecommerce products, our underwriting model looks at the health of a company — like their cash balance or sales — to provide a credit line instead of using a credit score.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Life sciences is Brex’s third vertical following the launch of our ecommerce product in February. You can be sure that this isn’t our last either as we work to empower companies around the world and provide them instant access to credit they need to continue driving innovation. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"You can get the new Brex for Life Sciences card by signing up today","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":".","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"About Brex","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Brex is transforming B2B payments by creating financial products that are tailored to specific industries, like ","nodeType":"text"},{"data":{"uri":"https://brex.com/startups/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"startups","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", ","nodeType":"text"},{"data":{"uri":"https://brex.com/ecommerce/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"ecommerce","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", and now ","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"life sciences","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". In 2018 Brex launched the first ","nodeType":"text"},{"data":{"uri":"https://brex.com/product/corporate-card/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"corporate card","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" and ","nodeType":"text"},{"data":{"uri":"https://brex.com/rewards/"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"rewards program","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" specifically designed for startups. By rebuilding the credit card tech stack from the ground up, Brex is able to reimagine every aspect of corporate cards, including underwriting, transparency and approvals, to create a radically better experience for customers. Brex has raised $215M in funding and is backed by Y Combinator Continuity, Peter Thiel, Max Levchin and more. The company’s headquarters are in San Francisco.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"We’re still early, and we welcome as much feedback as we can get. Also, we are hiring like crazy. Check out any ","nodeType":"text"},{"data":{"uri":"https://boards.greenhouse.io/brex"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"openings","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" we have!","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Photo credit: ","nodeType":"text"},{"data":{"uri":"https://unsplash.com/@cdrying?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText"},"content":[{"data":{},"marks":[],"value":"C Drying","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" on ","nodeType":"text"},{"data":{"uri":"https://unsplash.com/search/photos/scientist?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText"},"content":[{"data":{},"marks":[],"value":"Unsplash","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"},"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"urlPath":"life-sciences/empowering-life-sciences-brex-credit-card-launch","author":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"1grOGNNl0aZvhPKccFwBbf","type":"Entry","createdAt":"2019-05-09T23:32:28.456Z","updatedAt":"2019-06-06T18:11:43.389Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":3,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"author"}},"locale":"en-US"},"fields":{"name":"Matthew Lynley","picture":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3gWiGol7QRa3EmmTpB8vyf","type":"Asset","createdAt":"2019-05-31T00:41:30.951Z","updatedAt":"2019-05-31T00:41:30.951Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"matthew lynley headshot","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3gWiGol7QRa3EmmTpB8vyf/443e35d536a2dbcb07ce69e5b5ba3e31/mDoInk4z_400x400.jpg","details":{"size":28267,"image":{"width":400,"height":400}},"fileName":"mDoInk4z_400x400.jpg","contentType":"image/jpeg"}}},"description":"Product Marketing Manager at Brex","biography":"Matthew Lynley is a product marketing manager at Brex. Previously, he was a technology writer and journalist for more than 8 years. His work has been published in VentureBeat, The Wall Street Journal, BuzzFeed News, TechCrunch, and Business Insider.","twitterHandle":"https://www.twitter.com/mattlynley","linkedInHandle":"https://www.linkedin.com/in/matthew-lynley-74089011/"}},"isTopPost":false,"shouldFeature":false,"metaDescriptionTag":"Brex is launching a credit card with rewards tailored to the life sciences industry. Get best-in-class rewards when purchasing lab supplies, conference tickets, or travel.","metaTitleTag":"Brex credit card for life sciences launch | Brex","thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2pKxbNjRLq2Xu86G1ptfzj","type":"Asset","createdAt":"2019-09-04T21:04:45.833Z","updatedAt":"2019-09-04T21:04:45.833Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2pKxbNjRLq2Xu86G1ptfzj/6dde81e13f17f7bbbc1f19ba80339def/thumbnail__1_.png","details":{"size":137895,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"thumbnailImageRetina":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6xco0BN6FGip6DI45U2mxF","type":"Asset","createdAt":"2019-09-04T21:05:34.417Z","updatedAt":"2019-09-04T21:05:34.417Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"retina (2)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/6xco0BN6FGip6DI45U2mxF/2ca219c5bc6351ad590910b6bc0cef55/retina__2___1_.png","details":{"size":126977,"image":{"width":700,"height":400}},"fileName":"retina (2) (1).png","contentType":"image/png"}}},"articleLinks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3KWUKgegw4fbojx9pNgaEo","type":"Entry","createdAt":"2019-06-18T04:44:09.769Z","updatedAt":"2020-01-29T11:11:16.345Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":6,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5M9WlGaSaBF0CgOAt1bCj6","type":"Entry","createdAt":"2019-05-09T22:07:45.907Z","updatedAt":"2019-05-09T22:07:45.907Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Brex Research"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"1XlFbTWffrNBUdbeHQApjA","type":"Asset","createdAt":"2019-09-04T20:44:01.328Z","updatedAt":"2019-09-04T20:44:01.328Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"Thumbnail Preview","file":{"url":"//images.ctfassets.net/qlyedcbd6576/1XlFbTWffrNBUdbeHQApjA/c378d2a1595d05b53ecc2097f25ed8a1/thumbnail.png","details":{"size":137075,"image":{"width":350,"height":200}},"fileName":"thumbnail.png","contentType":"image/png"}}},"urlPath":"brex-research/boston-industry-breakdown-not-just-science-hub","title":"Boston's not a one-trick pony"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2wY1z7cJ57J5k9OpUlEAtr","type":"Entry","createdAt":"2019-06-18T17:21:47.528Z","updatedAt":"2020-02-05T10:05:37.190Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":11,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"71olfdL13ek6enPvVqajDu","type":"Asset","createdAt":"2019-11-27T19:04:05.556Z","updatedAt":"2019-11-27T19:04:05.556Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"billionToOne background","file":{"url":"//images.ctfassets.net/qlyedcbd6576/71olfdL13ek6enPvVqajDu/552e993a499dffefef8a6a038ae16c54/thumbnail__1_.png","details":{"size":43943,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"how-we-chose-our-third-vertical","title":"How we chose our third vertical: Brex for Life Sciences"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3XjqgsLmboxo81V956Cky0","type":"Entry","createdAt":"2019-06-18T04:44:47.568Z","updatedAt":"2020-02-04T13:22:38.434Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":4,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3Spl1gE9DbBefPzz3MpT5T","type":"Asset","createdAt":"2019-11-25T23:27:22.440Z","updatedAt":"2019-11-25T23:27:22.440Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3Spl1gE9DbBefPzz3MpT5T/db76e3d7cbc1cad47ab06f8f338c5b21/thumbnail__1_.png","details":{"size":38170,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/life-sciences-company-daily-reading-news-research","title":"The life sciences company daily reading list"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3cxdEYsx7H2uCvgBfwn4qC","type":"Entry","createdAt":"2019-06-18T04:44:31.924Z","updatedAt":"2020-02-05T10:24:21.028Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":5,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"662eQAs4zTrBzziSt82inK","type":"Asset","createdAt":"2019-11-25T23:24:15.364Z","updatedAt":"2019-11-25T23:24:15.364Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"lab beakers | Brex","file":{"url":"//images.ctfassets.net/qlyedcbd6576/662eQAs4zTrBzziSt82inK/4f37a4092a58e862190654e9a5faedf6/thumbnail__1_.png","details":{"size":48035,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/what-to-include-life-sciences-funding-pitch-deck","title":"What to include in your life sciences company fundraising pitch deck"}}]}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2wY1z7cJ57J5k9OpUlEAtr","type":"Entry","createdAt":"2019-06-18T17:21:47.528Z","updatedAt":"2020-02-05T10:05:37.190Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":11,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"title":"How we chose our third vertical: Brex for Life Sciences","date":"2019-06-18","heroImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5v7JRqpZDnBYSy0C2beKv3","type":"Asset","createdAt":"2019-11-27T19:04:21.789Z","updatedAt":"2019-11-27T19:04:21.789Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"billionToOne background","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5v7JRqpZDnBYSy0C2beKv3/df06e0c0b70d5a50ed46d14869f70e08/retina__1_.png","details":{"size":137836,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}},"heroImgAlt":"Image of DNA to represent life sciences","body":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"We just launched a corporate card specially tailored for ","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/"},"content":[{"data":{},"marks":[],"value":"Life Sciences companies","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". Every time we launch something new, we get a lot of questions about how we chose to prioritize this feature or product. I thought it’d be interesting to share our thoughts here with the community.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The thesis behind Brex is that each business is unique and therefore we should create tailored financial products to meet their specific circumstances. We want to be different from the legacy bank B2B financial approach of one or two sizes fit all. You can look at Chase Ink as an example offered to every type of business. With that said, there are commonalities between industries, so we carved out different niches in the business landscape and help solve their specific problems. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"While I’ve previously talked about launching our ","nodeType":"text"},{"data":{"uri":"https://news.ycombinator.com/item?id=17418813"},"content":[{"data":{},"marks":[],"value":"first tech startup card","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", this was a problem and a pain we experienced first hand. We, as a tech startup, couldn’t get a corporate card. Our goal was to accelerate entrepreneurs and scaling businesses, and we were also fortunate that this also created a great business opportunity. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The decision to launch Life Sciences was very different. We already had two existing products in the market with their own long list of improvements we wanted to make to them. We wanted to expand our product to serve a broader base and test our thesis that financial products tailored for specific industries could have value outside of the “tech bubble.”  ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"How we investigated the opportunity in Life Sciences","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"Rewind to 2 months ago and it was time for us to figure out what our next vertical would be. Our evaluation criteria was slightly different than it was for our ","nodeType":"text"},{"data":{"uri":"https://brex.com/ecommerce/"},"content":[{"data":{},"marks":[],"value":"ecommerce offering","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". To select an industry, we examined the revenue opportunity (the number of companies multiplied by their average card spend), what were their pain points around payments, how well did existing payment and financial solutions solve these, and. how well did we think our current value props would resonate. Finally, we thought about what the main acquisition channels would be. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Our first step was to consider revenue opportunity. We did this in two ways. First, we looked at the status quo financial institutions and asked if there were any other financial institutions that specifically targeted life sciences companies and what their revenue looked like. We found that Silicon Valley Bank has a whole ","nodeType":"text"},{"data":{"uri":"https://www.svb.com/life-sciences-healthcare"},"content":[{"data":{},"marks":[],"value":"life sciences division","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":".","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"In their ","nodeType":"text"},{"data":{"uri":"https://ir.svb.com/sec-filings/sec-filing/10-k/0000719739-19-000018"},"content":[{"data":{},"marks":[],"value":"2019 10-K","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", we’re able to see their life sciences financials and the profitability of their loans. They specifically call out life sciences, saying they “saw continued success in working with private equity/venture capital firms and life science/healthcare clients.” In addition to SVB, we also noticed that Comerica has a big life sciences practice. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"While these two large banks validated the notion that there was some revenue opportunity here, we also wanted to confirm this ourselves. Gathering a dataset from Pitchbook, Crunchbase, and the Biopharmaguy, we estimated how many life sciences companies there were and then used their funding amount to infer what we thought their monthly card spend could be. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The revenue opportunity we saw in Life Sciences was clearly nice and meaningful from a long term perspective, but it actually wasn’t the segment with the largest estimated revenue, so life sciences didn’t win because of pure revenue. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Next, we asked what were their main pain points with existing payment solutions. In a span of about a week, we got in touch with biotech CFOs, venture capitalists, business school professors, and early stage founders. We tried to immerse ourselves as much as possible. It’s amazing how much you can learn in a short amount of time — or perhaps how much you think you learned given there’s likely noise and outliers in conversations like these. We found that early stage life sciences companies faced very similar problems to tech startups, but actually faced them in a more acute way. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"How we executed on our life sciences go-to-market","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"We found that life sciences companies seemed to raise more money initially than tech companies and receive dramatically less revenue in the short term. This meant founders typically had to ","nodeType":"text"},{"data":{"uri":"https://brex.com/solution/founder-liability/"},"content":[{"data":{},"marks":[],"value":"personal guarantee","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" their credit card — or in the case of SVB, put down a security deposit — and received low monthly limits to the point where their card was mainly a vessel for travel and meal spend. Neither their grant nor equity funding was even considered in the underwriting process. The negligible revenue nature of the businesses meant maximizing the value out of every purchase, which are usually on lab supplies, was crucial. Finally, because a lot of these companies receive federal grant money, they have to manage their books very strictly. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"All of this meant that our existing value propositions, with some small tweaks, would be compelling to a typical life sciences company. We could underwrite them in a similar way to tech startups based on the cash balances in their bank account, which would account for both grants and equity. The presence of grants could also function as a means of protecting against fraud on our side, as fraudulent entities rarely receive grant funding. We could offer them differentiated rewards points on the vendors they care most about, like VWR and other lab supplies compared to Twilio and other B2B software. We could help them get the most value from their spend. And finally our existing ","nodeType":"text"},{"data":{"uri":"https://brex.com/solution/expense-management/"},"content":[{"data":{},"marks":[],"value":"expense management software","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" could help them spend less time on accounting and more time on R&D. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"The fit between their pain points and our existing solutions shocked us, but also got us really excited. We then asked ourselves if we’re already doing an 80% job at solving their problems, shouldn’t they already be using Brex? ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"We went through our customers (fortunately we categorized them by industry in the past) and found that we had only around a 1% market share of life sciences companies. We saw two potential hypotheses: either our customer research was wrong and the pain-points above weren’t really pain-points; or something about our messaging wasn’t clicking with the life sciences community. The latter would validate our premise that they think of themselves as unique relative to ","nodeType":"text"},{"data":{"uri":"https://brex.com/startups/"},"content":[{"data":{},"marks":[],"value":"tech startups","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":".","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Finally, we had to ask ourselves what would the go-to-market (GTM) look like. One of the things we learned with tech startups (and got caught off guard a bit with ecommerce) was how efficient distribution can be when there’s a concentrated pool of entities that your target market trusts. That's venture capital and accelerators for startups. Once you get the some of these “trusted nodes” to care about you, you end up with a good proportion of market share and then let word of mouth (and billboards!) take over. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Looking at life sciences, we found a similar dynamic with their own network of VC’s, accelerators, lab sharing spaces, and state associations like the California Life Sciences Association (which is now a one of our partners). Though these relationships are hard to get and take time, they serve to validate our product as solving real problems for our customers. This was definitely a positive as it meant we didn’t have to build a completely new distribution muscle. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"We found a relatively niche (but large) market that had a clear pain-point that we thought we could efficiently address. We could do so without investing a lot of extra resources for underwriting, product, and engineering. We already had experience building a similar GTM. However, there was risk in whether or not the market would find us compelling. We decided this was a worthwhile risk to take and believed if we created something for the life sciences community, customer adoption would follow. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"One important thing to note about our decision was that we assumed we would eventually go into each of the business verticals we were comparing. Looking back, this definitely impacted the decision making process. I imagine if we weren’t operating under this assumption we would have weighted overall revenue opportunity more.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"We spent the next month and a half figuring out what the final product would be and executing on our GTM. It’s interesting to look back at some of the things we thought we knew when we made the decision to enter life sciences compared to what we know now.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"I hope you found this interesting and informative. Please let me know if you’d like me to expand on anything (","nodeType":"text"},{"data":{"uri":"https://twitter.com/hdubugras?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor"},"content":[{"data":{},"marks":[],"value":"feel free to tweet at me","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"). We’re learning a lot about how to manage the extra organizational complexity that layering different products causes, so can share some insights about how we’ve thought about managing this too.","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"},"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"urlPath":"how-we-chose-our-third-vertical","author":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"UkYCjRwpSSnopoJi676Im","type":"Entry","createdAt":"2019-05-31T00:47:49.636Z","updatedAt":"2019-06-18T17:24:09.409Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":3,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"author"}},"locale":"en-US"},"fields":{"name":"Henrique Dubugras","picture":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"1MalIA6esdfIOW1NFwn8ay","type":"Asset","createdAt":"2019-05-31T00:46:53.115Z","updatedAt":"2019-05-31T00:46:53.115Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"henrique1","file":{"url":"//images.ctfassets.net/qlyedcbd6576/1MalIA6esdfIOW1NFwn8ay/ebf287423f2d82d70808cc5246019775/henrique1.jpg","details":{"size":51100,"image":{"width":500,"height":500}},"fileName":"henrique1.jpg","contentType":"image/jpeg"}}},"description":"Co-founder and CEO of Brex","biography":"Henrique is the co-founder and CEO of Brex.","twitterHandle":"https://twitter.com/hdubugras","linkedInHandle":"https://www.linkedin.com/in/henriquedubugras"}},"isTopPost":false,"shouldFeature":false,"metaDescriptionTag":"We wanted to expand our product to serve a broader base and test our thesis that financial products tailored for specific industries could have value outside of the “tech bubble.” We explored launching in a variety of industries and decided on life sciences for a couple of reasons.","metaTitleTag":"How we chose the life sciences industry as our third vertical | Brex","thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"71olfdL13ek6enPvVqajDu","type":"Asset","createdAt":"2019-11-27T19:04:05.556Z","updatedAt":"2019-11-27T19:04:05.556Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"billionToOne background","file":{"url":"//images.ctfassets.net/qlyedcbd6576/71olfdL13ek6enPvVqajDu/552e993a499dffefef8a6a038ae16c54/thumbnail__1_.png","details":{"size":43943,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"thumbnailImageRetina":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5v7JRqpZDnBYSy0C2beKv3","type":"Asset","createdAt":"2019-11-27T19:04:21.789Z","updatedAt":"2019-11-27T19:04:21.789Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"billionToOne background","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5v7JRqpZDnBYSy0C2beKv3/df06e0c0b70d5a50ed46d14869f70e08/retina__1_.png","details":{"size":137836,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}},"articleLinks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"488omE4YO9msYIN08YRTHP","type":"Entry","createdAt":"2019-06-25T01:41:18.208Z","updatedAt":"2020-02-04T13:25:45.159Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":4,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5rpbIR4JzCMaxvRz4cqzEL","type":"Asset","createdAt":"2019-11-25T22:33:46.000Z","updatedAt":"2019-11-25T22:33:46.000Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"conferences crowd | Brex","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5rpbIR4JzCMaxvRz4cqzEL/3ddbcb07ca654709cdafff763f19657d/thumbnail__1_.png","details":{"size":35140,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/life-sciences-conference-list-jpmorgan-health-bio-international-acmg-synbiobeta","title":"A list of some top life sciences conferences to attend"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3KWUKgegw4fbojx9pNgaEo","type":"Entry","createdAt":"2019-06-18T04:44:09.769Z","updatedAt":"2020-01-29T11:11:16.345Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":6,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5M9WlGaSaBF0CgOAt1bCj6","type":"Entry","createdAt":"2019-05-09T22:07:45.907Z","updatedAt":"2019-05-09T22:07:45.907Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Brex Research"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"1XlFbTWffrNBUdbeHQApjA","type":"Asset","createdAt":"2019-09-04T20:44:01.328Z","updatedAt":"2019-09-04T20:44:01.328Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"Thumbnail Preview","file":{"url":"//images.ctfassets.net/qlyedcbd6576/1XlFbTWffrNBUdbeHQApjA/c378d2a1595d05b53ecc2097f25ed8a1/thumbnail.png","details":{"size":137075,"image":{"width":350,"height":200}},"fileName":"thumbnail.png","contentType":"image/png"}}},"urlPath":"brex-research/boston-industry-breakdown-not-just-science-hub","title":"Boston's not a one-trick pony"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"SxZqKUPisHvANdRSvMW4R","type":"Entry","createdAt":"2019-06-05T18:14:38.798Z","updatedAt":"2020-02-05T09:33:57.734Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":5,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5dghPM8m93N5HuVbxgtJMe","type":"Entry","createdAt":"2019-04-09T21:48:44.059Z","updatedAt":"2019-04-09T21:48:44.059Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Scaling"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5VqMNwnAByrQexh6jQhLWw","type":"Asset","createdAt":"2019-11-25T23:07:18.985Z","updatedAt":"2019-11-25T23:07:18.985Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"Brex talks: when and why to launch your second product","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5VqMNwnAByrQexh6jQhLWw/9621c9ff13145f9475f04afe130212dc/thumbnail__1_.png","details":{"size":45310,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"brex-talks-when-to-launch-your-separate-product","title":"Brex talks: when and why to launch your second product"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3Y2mKO0hEzIMG6zPeP984q","type":"Entry","createdAt":"2019-06-18T04:43:54.329Z","updatedAt":"2020-02-05T11:36:16.929Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":10,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2pKxbNjRLq2Xu86G1ptfzj","type":"Asset","createdAt":"2019-09-04T21:04:45.833Z","updatedAt":"2019-09-04T21:04:45.833Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2pKxbNjRLq2Xu86G1ptfzj/6dde81e13f17f7bbbc1f19ba80339def/thumbnail__1_.png","details":{"size":137895,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/empowering-life-sciences-brex-credit-card-launch","title":"Empowering life sciences with a tailored credit card product"}}]}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3KWUKgegw4fbojx9pNgaEo","type":"Entry","createdAt":"2019-06-18T04:44:09.769Z","updatedAt":"2020-01-29T11:11:16.345Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":6,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"title":"Boston's not a one-trick pony","date":"2019-06-18","heroImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5CcPXexRdiGpa8h5KsjZoM","type":"Asset","createdAt":"2019-06-18T01:26:14.540Z","updatedAt":"2019-09-04T20:47:38.033Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":2,"locale":"en-US"},"fields":{"title":"boston skyline 1","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5CcPXexRdiGpa8h5KsjZoM/01936288a557b0189344dfb37c18c71f/zoltan-kovacs-272629-unsplash__1_.jpg","details":{"size":165879,"image":{"width":1400,"height":968}},"fileName":"zoltan-kovacs-272629-unsplash (1).jpg","contentType":"image/jpeg"}}},"heroImgAlt":"Image of Boston Skyline","body":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Boston sometimes has a reputation that it’s a science town. And the reality is there’s some truth to it — but it’s far from the only thing Boston has going for it.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Massachusetts is loaded with research institutions that produce engineers in some of the top emerging technology fields. ","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/"},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"Life Sciences is one of the most important growing research and engineering fields. New technologies like machine learning are enabling cutting-edge research into some of the most difficult problems in the modern era. But like any city across the United States, that doesn’t mean it’s a hub for only one industry.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"So, where does Boston ","nodeType":"text"},{"data":{},"marks":[{"type":"italic"}],"value":"really","nodeType":"text"},{"data":{},"marks":[],"value":" stack up across major regions when it comes to life sciences?","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"To get a closer look, we examined Brex customer data across a few states. California and New York represent our largest markets, while Massachusetts (effectively Boston) represents an emerging market with a bit of different behavior. In this, we can see that startups identifying as Healthcare and Biotechnology, Engineering, and Science (as a combined group) represent two of the top three industries found in the Boston area. Software represents the second-largest, though there is likely some overlap between that and companies working in Life Sciences.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Still, the notion that Boston is ","nodeType":"text"},{"data":{},"marks":[{"type":"italic"}],"value":"just","nodeType":"text"},{"data":{},"marks":[],"value":" a science town still isn’t the whole picture — just a part of it.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Home-field advantage for life sciences","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"When you look at our customer distribution, you can see a pretty straightforward trend: the Boston startup scene is a bit different than others when it comes to Brex customers. Our customer base consists primarily of ","nodeType":"text"},{"data":{"uri":"https://brex.com/startups/"},"content":[{"data":{},"marks":[],"value":"startups","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":", though we have a growing ","nodeType":"text"},{"data":{"uri":"https://brex.com/ecommerce/"},"content":[{"data":{},"marks":[],"value":"e-commerce","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" base and are now expanding into ","nodeType":"text"},{"data":{"uri":"https://brex.com/industry/life-sciences/"},"content":[{"data":{},"marks":[],"value":"life sciences","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":". But even though we are only now launching our product targeted specifically to life sciences, we have a solid base of biotechnology, science, and engineering startups.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"When you dig into the kinds of industries prominent in some of our largest markets, you’ll actually see some of the common regional tropes emerge. New York’s a finance town, the Bay Area’s a software region, and Boston is… well, you can see for yourself below:","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5xgShCGnAuZ6wl8Vxz13eo","type":"Asset","createdAt":"2019-06-18T01:20:24.000Z","updatedAt":"2019-06-18T01:20:24.000Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"boston industry chart 1","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5xgShCGnAuZ6wl8Vxz13eo/1ce730d2e368a97db387ae5bef35f19e/bostonpony2.png","details":{"size":57698,"image":{"width":2007,"height":1192}},"fileName":"bostonpony2.png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"\nIt’s not quite the Bay Area, but it’s not quite New York either. You can find schools like Boston College, Boston University, Harvard, MIT, Cambridge, and others all within — or not too far — from Boston proper.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Boston clearly does a pretty good job of retaining biotechs as residents, even if they end up under a few feet of snow most winters. There are the lobster rolls, the direct flights to anywhere around the world, the actually functional public transportation, and so on and so forth. And aside of poorly-designed fields (just google the ","nodeType":"text"},{"data":{"uri":"https://en.wikipedia.org/wiki/Green_Monster"},"content":[{"data":{},"marks":[{"type":"underline"}],"value":"Green Monster","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"), Boston has a history of winning sports franchises with the Celtics, Patriots, and Red Sox. Boston, in short, has a lot of things going for it.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"But still, as we can see, Boston’s specialties still go beyond biotechnology, science, and engineering. There are plenty of startups that aren’t that field that are starting to gain traction. There are companies like Botkeeper that are trying to rethink accounting software. Fuze is building enterprise collaboration tools. And the region is home to a lot of work on autonomous driving.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Going beyond what the map calls Boston","nodeType":"text"}],"nodeType":"heading-2"},{"data":{},"content":[{"data":{},"marks":[],"value":"Boston may get its own independent chunk of Google Maps. Meanwhile, you can look across the river to see a little bit of where the DNA comes from for the whole region.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2zyWcD48M0HwrMYKPP1NIf","type":"Asset","createdAt":"2019-06-18T01:21:59.650Z","updatedAt":"2019-06-18T01:21:59.650Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"boston cambridge comparison","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2zyWcD48M0HwrMYKPP1NIf/9f694d165fccb63700d92f46332dcfb0/bostoncambridge.png","details":{"size":50821,"image":{"width":1631,"height":1188}},"fileName":"bostoncambridge.png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"Now ","nodeType":"text"},{"data":{},"marks":[{"type":"italic"}],"value":"there’s","nodeType":"text"},{"data":{},"marks":[],"value":" a science town. Cambridge is, again, home to some of the top scientific academic institutions in the United States — and the world proper. If we take a step back and we look at the industries at a state level to wrap up Cambridge, Boston, and Somerville (another small-ish hotspot) with a bow, we start to see where the idea is born.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{"target":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"10WpMbTF1foJkEi4NE4GPr","type":"Asset","createdAt":"2019-06-18T01:22:38.667Z","updatedAt":"2019-06-18T01:22:38.667Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"boston area science hub","file":{"url":"//images.ctfassets.net/qlyedcbd6576/10WpMbTF1foJkEi4NE4GPr/330925e13d15d009b5922fb055ad4acb/bostonhub3.png","details":{"size":51074,"image":{"width":2151,"height":1233}},"fileName":"bostonhub3.png","contentType":"image/png"}}}},"content":[],"nodeType":"embedded-asset-block"},{"data":{},"content":[{"data":{},"marks":[],"value":"What we can find is that the whole region is inevitably linked together into a mesh that creates a very vibrant startup community beyond the sciences. But there’s absolutely no denying that the whole Boston region has a very strong science bent to it — even more so than the entirety of California (including Los Angeles). ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Life sciences companies have an opportunity to dramatically reshape the future of the entire human race. And it’s clear that Boston will continue to be a hub for innovation for that kind of work. And maybe twenty years from now we’ll all look back and remember the crazy innovation, rather than Tom Brady deflating a few footballs.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"bold"}],"value":"Methodology","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Brex examined the regional presence of its customer base to learn more about how startups and industries are distributed across our major markets. Brex customers identify as startups within a number of different industries. For this report, we combined startups identifying as Biotechnology and Science and Engineering as a single category. ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Share of industry is defined as the total number of startups in one region over the total number of startups for a given industry. Median burn rate is defined by the median average monthly burn for all startups in a specific region or industry.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[{"type":"italic"}],"value":"As part of its underwriting process, Brex maintains visibility into the spending of companies that use its products. Companies who asked that their data not to be shared were not used, and any company that does not wish to share its data for future aggregated analysis may request to exclude it from being shared in the aggregate.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Photo credit","nodeType":"text"},{"data":{},"marks":[{"type":"italic"}],"value":": ","nodeType":"text"},{"data":{"uri":"https://unsplash.com/@kovacsz1?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText"},"content":[{"data":{},"marks":[],"value":"Zoltan Kovacs","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":" on ","nodeType":"text"},{"data":{"uri":"https://unsplash.com/search/photos/boston?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText"},"content":[{"data":{},"marks":[],"value":"Unsplash","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[{"type":"italic"}],"value":"","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"},"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5M9WlGaSaBF0CgOAt1bCj6","type":"Entry","createdAt":"2019-05-09T22:07:45.907Z","updatedAt":"2019-05-09T22:07:45.907Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Brex Research"}},"urlPath":"brex-research/boston-industry-breakdown-not-just-science-hub","author":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"1grOGNNl0aZvhPKccFwBbf","type":"Entry","createdAt":"2019-05-09T23:32:28.456Z","updatedAt":"2019-06-06T18:11:43.389Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":3,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"author"}},"locale":"en-US"},"fields":{"name":"Matthew Lynley","picture":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3gWiGol7QRa3EmmTpB8vyf","type":"Asset","createdAt":"2019-05-31T00:41:30.951Z","updatedAt":"2019-05-31T00:41:30.951Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"matthew lynley headshot","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3gWiGol7QRa3EmmTpB8vyf/443e35d536a2dbcb07ce69e5b5ba3e31/mDoInk4z_400x400.jpg","details":{"size":28267,"image":{"width":400,"height":400}},"fileName":"mDoInk4z_400x400.jpg","contentType":"image/jpeg"}}},"description":"Product Marketing Manager at Brex","biography":"Matthew Lynley is a product marketing manager at Brex. Previously, he was a technology writer and journalist for more than 8 years. His work has been published in VentureBeat, The Wall Street Journal, BuzzFeed News, TechCrunch, and Business Insider.","twitterHandle":"https://www.twitter.com/mattlynley","linkedInHandle":"https://www.linkedin.com/in/matthew-lynley-74089011/"}},"isTopPost":true,"shouldFeature":true,"metaDescriptionTag":"The Boston area is home to some of the top research universities and institutions in the world — but it isn't just a science town. Brex data shows that there's a diverse set of industries that power the Boston startup scene.","metaTitleTag":"Boston is not just a life sciences city | Brex","thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"1XlFbTWffrNBUdbeHQApjA","type":"Asset","createdAt":"2019-09-04T20:44:01.328Z","updatedAt":"2019-09-04T20:44:01.328Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"Thumbnail Preview","file":{"url":"//images.ctfassets.net/qlyedcbd6576/1XlFbTWffrNBUdbeHQApjA/c378d2a1595d05b53ecc2097f25ed8a1/thumbnail.png","details":{"size":137075,"image":{"width":350,"height":200}},"fileName":"thumbnail.png","contentType":"image/png"}}},"thumbnailImageRetina":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"tDKBXwymMY4TRtVZCQB2D","type":"Asset","createdAt":"2019-09-04T20:46:18.806Z","updatedAt":"2019-09-04T20:46:18.806Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"Thumbnail Preview Retina","file":{"url":"//images.ctfassets.net/qlyedcbd6576/tDKBXwymMY4TRtVZCQB2D/fe5d3cda528a8b7759ca07df9fd00257/retina__1_.png","details":{"size":122937,"image":{"width":700,"height":400}},"fileName":"retina (1).png","contentType":"image/png"}}},"articleLinks":[{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"488omE4YO9msYIN08YRTHP","type":"Entry","createdAt":"2019-06-25T01:41:18.208Z","updatedAt":"2020-02-04T13:25:45.159Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":4,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"5rpbIR4JzCMaxvRz4cqzEL","type":"Asset","createdAt":"2019-11-25T22:33:46.000Z","updatedAt":"2019-11-25T22:33:46.000Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"conferences crowd | Brex","file":{"url":"//images.ctfassets.net/qlyedcbd6576/5rpbIR4JzCMaxvRz4cqzEL/3ddbcb07ca654709cdafff763f19657d/thumbnail__1_.png","details":{"size":35140,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/life-sciences-conference-list-jpmorgan-health-bio-international-acmg-synbiobeta","title":"A list of some top life sciences conferences to attend"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3Y2mKO0hEzIMG6zPeP984q","type":"Entry","createdAt":"2019-06-18T04:43:54.329Z","updatedAt":"2020-02-05T11:36:16.929Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":10,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"2pKxbNjRLq2Xu86G1ptfzj","type":"Asset","createdAt":"2019-09-04T21:04:45.833Z","updatedAt":"2019-09-04T21:04:45.833Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/2pKxbNjRLq2Xu86G1ptfzj/6dde81e13f17f7bbbc1f19ba80339def/thumbnail__1_.png","details":{"size":137895,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/empowering-life-sciences-brex-credit-card-launch","title":"Empowering life sciences with a tailored credit card product"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3XjqgsLmboxo81V956Cky0","type":"Entry","createdAt":"2019-06-18T04:44:47.568Z","updatedAt":"2020-02-04T13:22:38.434Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":4,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3Spl1gE9DbBefPzz3MpT5T","type":"Asset","createdAt":"2019-11-25T23:27:22.440Z","updatedAt":"2019-11-25T23:27:22.440Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"thumbnail (1)","file":{"url":"//images.ctfassets.net/qlyedcbd6576/3Spl1gE9DbBefPzz3MpT5T/db76e3d7cbc1cad47ab06f8f338c5b21/thumbnail__1_.png","details":{"size":38170,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/life-sciences-company-daily-reading-news-research","title":"The life sciences company daily reading list"}},{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"3cxdEYsx7H2uCvgBfwn4qC","type":"Entry","createdAt":"2019-06-18T04:44:31.924Z","updatedAt":"2020-02-05T10:24:21.028Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":5,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"genericPost"}},"locale":"en-US"},"fields":{"category":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"6PiSaGQKiTHouqiHFoZyml","type":"Entry","createdAt":"2019-06-17T23:36:50.950Z","updatedAt":"2019-06-17T23:36:50.950Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"contentType":{"sys":{"type":"Link","linkType":"ContentType","id":"category"}},"locale":"en-US"},"fields":{"title":"Life Sciences"}},"thumbnailImage":{"sys":{"space":{"sys":{"type":"Link","linkType":"Space","id":"qlyedcbd6576"}},"id":"662eQAs4zTrBzziSt82inK","type":"Asset","createdAt":"2019-11-25T23:24:15.364Z","updatedAt":"2019-11-25T23:24:15.364Z","environment":{"sys":{"id":"master","type":"Link","linkType":"Environment"}},"revision":1,"locale":"en-US"},"fields":{"title":"lab beakers | Brex","file":{"url":"//images.ctfassets.net/qlyedcbd6576/662eQAs4zTrBzziSt82inK/4f37a4092a58e862190654e9a5faedf6/thumbnail__1_.png","details":{"size":48035,"image":{"width":350,"height":200}},"fileName":"thumbnail (1).png","contentType":"image/png"}}},"urlPath":"life-sciences/what-to-include-life-sciences-funding-pitch-deck","title":"What to include in your life sciences company fundraising pitch deck"}}]}}]}}}}